1. Home
  2. STBX vs RLYB Comparison

STBX vs RLYB Comparison

Compare STBX & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STBX
  • RLYB
  • Stock Information
  • Founded
  • STBX 2019
  • RLYB 2018
  • Country
  • STBX Malaysia
  • RLYB United States
  • Employees
  • STBX N/A
  • RLYB N/A
  • Industry
  • STBX Advertising
  • RLYB Biotechnology: Pharmaceutical Preparations
  • Sector
  • STBX Consumer Discretionary
  • RLYB Health Care
  • Exchange
  • STBX Nasdaq
  • RLYB Nasdaq
  • Market Cap
  • STBX 51.1M
  • RLYB 45.6M
  • IPO Year
  • STBX 2022
  • RLYB 2021
  • Fundamental
  • Price
  • STBX $0.13
  • RLYB $1.08
  • Analyst Decision
  • STBX
  • RLYB Buy
  • Analyst Count
  • STBX 0
  • RLYB 6
  • Target Price
  • STBX N/A
  • RLYB $8.30
  • AVG Volume (30 Days)
  • STBX 99.8K
  • RLYB 50.8K
  • Earning Date
  • STBX 10-22-2024
  • RLYB 11-07-2024
  • Dividend Yield
  • STBX N/A
  • RLYB N/A
  • EPS Growth
  • STBX N/A
  • RLYB N/A
  • EPS
  • STBX N/A
  • RLYB N/A
  • Revenue
  • STBX $12,213,183.00
  • RLYB $299,000.00
  • Revenue This Year
  • STBX N/A
  • RLYB N/A
  • Revenue Next Year
  • STBX N/A
  • RLYB N/A
  • P/E Ratio
  • STBX N/A
  • RLYB N/A
  • Revenue Growth
  • STBX 48.08
  • RLYB N/A
  • 52 Week Low
  • STBX $0.10
  • RLYB $1.08
  • 52 Week High
  • STBX $1.05
  • RLYB $4.60
  • Technical
  • Relative Strength Index (RSI)
  • STBX 39.62
  • RLYB 42.14
  • Support Level
  • STBX $0.11
  • RLYB $1.09
  • Resistance Level
  • STBX $0.13
  • RLYB $1.18
  • Average True Range (ATR)
  • STBX 0.01
  • RLYB 0.04
  • MACD
  • STBX 0.00
  • RLYB 0.00
  • Stochastic Oscillator
  • STBX 48.28
  • RLYB 0.00

About STBX Starbox Group Holdings Ltd.

Starbox Group Holdings Ltd engages in developing cash rebate, digital advertising, and payment solution business ecosystem targeting micro, small, and medium enterprises. Through the firm's subsidiaries in Malaysia, it connects retail merchants with retail shoppers to facilitate transactions through cash rebates offered by retail merchants, provide digital advertising services to advertisers, and provide payment solution services to merchants. Substantially all of its current operations are located in Malaysia. It operates in five segments include Cash rebate, payment solution, and media booking, Advertising services, Software licensing and Production services, Marketing and Promotional campaign services segment.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: